162 results
Page 3 of 9
8-K
EX-10.01
bf4dh3c2s1iv zz7t9uu
26 Jan 22
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
8:05am
8-K
EX-99.1
eh48e7dngf6whjd6
25 Feb 21
Adaptimmune Reports Fourth Quarter / Full Year 2020 Financial Results and Business Update
7:37am
8-K
EX-10.1
tu1infyc
16 Dec 20
Departure of Directors or Certain Officers
5:01pm
8-K
wu3ftrg ke5m
20 Nov 20
Regulation FD Disclosure
7:36am
8-K
EX-99.1
10ajsvqf
20 Nov 20
Regulation FD Disclosure
7:36am
8-K
EX-99.1
i8dfa837mp367
5 Nov 20
Adaptimmune Reports Q3 Financial Results and Business Update
7:40am
S-3ASR
mtg07h2wm0g
10 Aug 20
Automatic shelf registration
5:01pm
S-3ASR
EX-1.2
dkylqm
10 Aug 20
Automatic shelf registration
5:01pm
8-K
EX-99.1
0655bhhmzx eq0g
6 Aug 20
Adaptimmune Reports Q2 Financial Results and Business Update
7:37am
424B5
y7c7i1ws64dckgp5a
2 Jun 20
Prospectus supplement for primary offering
5:05pm
8-K
EX-1.1
r9chn nte
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm